✦ LIBER ✦

Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis

✍ Scribed by Susumu Takano; Masao Omata; Masao Oht; Yoichi Satomura

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 550 KB
Volume: 18
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840180202

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective assessment of donor blood sc

Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis

✍ S Takano; K Nakamura; S Kawai; O Yokosuka; Y Satomura; M Omata 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

In November 1989, the Japanese Red Cross began transfusion. [4][5][6] In December 1989, first-generation hepscreening blood donors for the hepatitis C virus antiatitis C virus antibodies (anti-HCV) to detect the antibody (anti-HCV) by first-generation assay and high-titer body against nonstructural

Prevention of posttransfusion hepatitis

Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg

✍ Hau Tim Chung; Joseph Sai Kit Lee; Anna Suk Fong Lok 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

Prospective assessment of donor blood sc

Prospective assessment of donor blood screening for antibody to hepatitis B core antigen as a means of preventing posttransfusion non-A, non-B, hepatitis

✍ Melchor Hoyos; José V. Sarrión; Teresa Pérez-Castellanos; Martín Prieto; María L 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB 👁 1 views

heart surgery at out institution were prospectively studied. Inclusion crit,eria were the following: absence of transfusion or acute hepatitis during the prior year, alcohol intake <80 gm per day. absence of the use of hepatotoxic drugs, normal aminotransferase values and negative hepatitis B virus

Efficacy of screening donors for antibod

Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: Final report of a prospective trial

✍ Antonio González; Juan I. Esteban; Pedro Madoz; Luis Viladomiu; Juan Genesca; Ed 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 852 KB

Routine screening of blood donors for anti-hepatitis C virus (HCV) has been implemented in most developed countries. However, the independent efficacy of such screening has not been established in a controlled, prospective study. We tracked 478 patients transfused with anti-HCV-negative blood by fir